Report Code: 10210 | Available Format: PDF | Pages: 344
In Vitro Diagnostic (IVD) Market Research Report: By Offering (Reagents & Kits, Instruments, Software & Services), Technology (Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology, Microbiology), Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Nephrology, Autoimmune Diseases), End User (Hospitals & Clinics, Point of Care, Laboratories, Research & Academic Institutes) - Global Industry Analysis and Growth Forecast to 2030
- Report Code: 10210
- Available Format: PDF
- Pages: 344
- Report Description
- Table of Contents
- Market Segmentation
- Request Free Sample
Chapter 1. Research Background
1.1 Research Objectives
1.2 Market Definition
1.3 Research Scope
1.3.1 Market Segmentation by Offering
1.3.2 Market Segmentation by Technology
1.3.3 Market Segmentation by Application
1.3.4 Market Segmentation by End User
1.3.5 Market Segmentation by Region
1.3.6 Analysis Period
1.3.7 Market Data Reporting Unit
1.3.7.1 Value
1.4 Key Stakeholders
Chapter 2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.2.1 Breakdown of Primary Research Respondents
2.2.1.1 By region
2.2.1.2 By industry participant
2.2.1.3 By company type
2.3 Market Size Estimation
2.4 Data Triangulation
2.5 Assumptions for the Study
Chapter 3. Executive Summary
Chapter 4. Introduction
4.1 Definition of Market Segments
4.1.1 By Offering
4.1.1.1 Reagents & kits
4.1.1.2 Instruments
4.1.1.3 Software & services
4.1.2 By Technology
4.1.2.1 Clinical chemistry
4.1.2.1.1 Basic metabolic panel
4.1.2.1.2 Lipid profile
4.1.2.1.3 Liver profile
4.1.2.1.4 Renal profile
4.1.2.1.5 Thyroid function panel
4.1.2.1.6 Others
4.1.2.2 Immunochemistry
4.1.2.2.1 ELISA
4.1.2.2.2 RIA
4.1.2.2.3 FIA
4.1.2.2.4 CLIA
4.1.2.2.5 ICA
4.1.2.2.6 Others
4.1.2.3 Molecular diagnostics
4.1.2.3.1 Infectious diseases
4.1.2.3.2 Genomics
4.1.2.3.3 Blood donor screening
4.1.2.3.4 Others
4.1.2.4 Hematology
4.1.2.4.1 CBC
4.1.2.4.2 Cholesterol testing
4.1.2.4.3 Blood glucose testing
4.1.2.4.4 Hemoglobin testing
4.1.2.4.5 Coagulation testing
4.1.2.4.6 Others
4.1.2.5 Others
4.1.3 By Application
4.1.3.1 Infectious diseases
4.1.3.2 Diabetes
4.1.3.3 Oncology
4.1.3.4 Cardiology
4.1.3.5 Nephrology
4.1.3.6 Autoimmune diseases
4.1.3.7 Others
4.1.4 By End User
4.1.4.1 Hospitals & clinics
4.1.4.2 POC
4.1.4.3 Research & academic institutes
4.2 Market Dynamics
4.2.1 Trends
4.2.1.1 Approval and launch of new products
4.2.1.2 Increasing number of collaborations and agreements
4.2.2 Drivers
4.2.2.1 Regulations with respect to blood safety and sample contamination
4.2.2.2 Surging burden of chronic diseases
4.2.2.3 Increasing number of blood donors
4.2.2.4 Advancements in IVD technology
4.2.2.5 Increasing healthcare expenditure
4.2.2.6 Increasing number of hospitals and academic institutes
4.2.2.7 Impact analysis of drivers on the market forecast period
4.2.3 Restraints
4.2.3.1 Challenges in maintaining sufficient, safe sample supply
4.2.3.2 Data insecurity over donors’ demographic information
4.2.3.3 Cost-ineffectiveness of IVD products
4.2.3.4 Impact analysis of restraints on the market forecast
4.3 Porter’s Five Forces Analysis
4.4 Impact of COVID-19
Chapter 5. Global Market Size and Forecast
5.1 By Offering
5.2 By Technology
5.2.1 IVD Market for Clinical Chemistry, by Type
5.2.2 IVD Market for Immunochemistry, by Type
5.2.3 IVD Market for Molecular Diagnostics, by Type
5.2.4 IVD Market for Hematology, by Type
5.3 By Application
5.4 By End User
5.5 By Region
Chapter 6. North America Market Size and Forecast
6.1 By Offering
6.2 By Technology
6.2.1 IVD Market for Clinical Chemistry, by Type
6.2.2 IVD Market for Immunochemistry, by Type
6.2.3 IVD Market for Molecular Diagnostics, by Type
6.2.4 IVD Market for Hematology, by Type
6.3 By Application
6.4 By End User
6.5 By Country
6.5.1 U.S. Market Size and Forecast
6.5.1.1 By offering
6.5.1.2 By technology
6.5.1.2.1 IVD market for clinical chemistry, by type
6.5.1.2.2 IVD market for immunochemistry, by type
6.5.1.2.3 IVD market for molecular diagnostics, by type
6.5.1.2.4 IVD market for hematology, by type
6.5.1.3 By application
6.5.1.4 By end user
6.5.2 Canada Market Size and Forecast
6.5.2.1 By offering
6.5.2.2 By technology
6.5.2.2.1 IVD market for clinical chemistry, by type
6.5.2.2.2 IVD market for immunochemistry, by type
6.5.2.2.3 IVD market for molecular diagnostics, by type
6.5.2.2.4 IVD market for hematology, by type
6.5.2.3 By application
6.5.2.4 By end user
Chapter 7. Europe Market Size and Forecast
7.1 By Offering
7.2 By Technology
7.2.1 IVD Market for Clinical Chemistry, by Type
7.2.2 IVD Market for Immunochemistry, by Type
7.2.3 IVD Market for Molecular Diagnostics, by Type
7.2.4 IVD Market for Hematology, by Type
7.3 By Application
7.4 By End User
7.5 By Country
7.5.1 Germany Market Size and Forecast
7.5.1.1 By offering
7.5.1.2 By technology
7.5.1.2.1 IVD market for clinical chemistry, by type
7.5.1.2.2 IVD market for immunochemistry, by type
7.5.1.2.3 IVD market for molecular diagnostics, by type
7.5.1.2.4 IVD market for hematology, by type
7.5.1.3 By application
7.5.1.4 By end user
7.5.2 France Market Size and Forecast
7.5.2.1 By offering
7.5.2.2 By technology
7.5.2.2.1 IVD market for clinical chemistry, by type
7.5.2.2.2 IVD market for immunochemistry, by type
7.5.2.2.3 IVD market for molecular diagnostics, by type
7.5.2.2.4 IVD market for hematology, by type
7.5.2.3 By application
7.5.2.4 By end user
7.5.3 Italy Market Size and Forecast
7.5.3.1 By offering
7.5.3.2 By technology
7.5.3.2.1 IVD market for clinical chemistry, by type
7.5.3.2.2 IVD market for immunochemistry, by type
7.5.3.2.3 IVD market for molecular diagnostics, by type
7.5.3.2.4 IVD market for hematology, by type
7.5.3.3 By application
7.5.3.4 By end user
7.5.4 Spain Market Size and Forecast
7.5.4.1 By offering
7.5.4.2 By technology
7.5.4.2.1 IVD market for clinical chemistry, by type
7.5.4.2.2 IVD market for immunochemistry, by type
7.5.4.2.3 IVD market for molecular diagnostics, by type
7.5.4.2.4 IVD market for hematology, by type
7.5.4.3 By application
7.5.4.4 By end user
7.5.5 U.K. Market Size and Forecast
7.5.5.1 By offering
7.5.5.2 By technology
7.5.5.2.1 IVD market for clinical chemistry, by type
7.5.5.2.2 IVD market for immunochemistry, by type
7.5.5.2.3 IVD market for molecular diagnostics, by type
7.5.5.2.4 IVD market for hematology, by type
7.5.5.3 By application
7.5.5.4 By end user
Chapter 8. APAC Market Size and Forecast
8.1 By offering
8.2 By Technology
8.2.1 IVD Market for Clinical Chemistry, by Type
8.2.2 IVD Market for Immunochemistry, by Type
8.2.3 IVD Market for Molecular Diagnostics, by Type
8.2.4 IVD Market for Hematology, by Type
8.3 By Application
8.4 By End User
8.5 By Country
8.5.1 China Market Size and Forecast
8.5.1.1 By offering
8.5.1.2 By technology
8.5.1.2.1 IVD market for clinical chemistry, by type
8.5.1.2.2 IVD market for immunochemistry, by type
8.5.1.2.3 IVD market for molecular diagnostics, by type
8.5.1.2.4 IVD market for hematology, by type
8.5.1.3 By application
8.5.1.4 By end user
8.5.2 Japan Market Size and Forecast
8.5.2.1 By offering
8.5.2.2 By technology
8.5.2.2.1 IVD market for clinical chemistry, by type
8.5.2.2.2 IVD market for immunochemistry, by type
8.5.2.2.3 IVD market for molecular diagnostics, by type
8.5.2.2.4 IVD market for hematology, by type
8.5.2.3 By application
8.5.2.4 By end user
8.5.3 India Market Size and Forecast
8.5.3.1 By offering
8.5.3.2 By technology
8.5.3.2.1 IVD market for clinical chemistry, by type
8.5.3.2.2 IVD market for immunochemistry, by type
8.5.3.2.3 IVD market for molecular diagnostics, by type
8.5.3.2.4 IVD market for hematology, by type
8.5.3.3 By application
8.5.3.4 By end user
Chapter 9. LATAM Market Size and Forecast
9.1 By offering
9.2 By Technology
9.2.1 IVD Market for Clinical Chemistry, by Type
9.2.2 IVD Market for Immunochemistry, by Type
9.2.3 IVD Market for Molecular Diagnostics, by Type
9.2.4 IVD Market for Hematology, by Type
9.3 By Application
9.4 By End User
9.5 By Country
9.5.1 Brazil Market Size and Forecast
9.5.1.1 By offering
9.5.1.2 By technology
9.5.1.2.1 IVD market for clinical chemistry, by type
9.5.1.2.2 IVD market for immunochemistry, by type
9.5.1.2.3 IVD market for molecular diagnostics, by type
9.5.1.2.4 IVD market for hematology, by type
9.5.1.3 By application
9.5.1.4 By end user
9.5.2 Mexico Market Size and Forecast
9.5.2.1 By offering
9.5.2.2 By technology
9.5.2.2.1 IVD market for clinical chemistry, by type
9.5.2.2.2 IVD market for immunochemistry, by type
9.5.2.2.3 IVD market for molecular diagnostics, by type
9.5.2.2.4 IVD market for hematology, by type
9.5.2.3 By application
9.5.2.4 By end user
Chapter 10. MEA Market Size and Forecast
10.1 By offering
10.2 By Technology
10.2.1 IVD Market for Clinical Chemistry, by Type
10.2.2 IVD Market for Immunochemistry, by Type
10.2.3 IVD Market for Molecular Diagnostics, by Type
10.2.4 IVD Market for Hematology, by Type
10.3 By Application
10.4 By End User
10.5 By Country
10.5.1 Saudi Arabia Market Size and Forecast
10.5.1.1 By offering
10.5.1.2 By technology
10.5.1.2.1 IVD market for clinical chemistry, by type
10.5.1.2.2 IVD market for immunochemistry, by type
10.5.1.2.3 IVD market for molecular diagnostics, by type
10.5.1.2.4 IVD market for hematology, by type
10.5.1.3 By application
10.5.1.4 By end user
10.5.2 South Africa Market Size and Forecast
10.5.2.1 By offering
10.5.2.2 By technology
10.5.2.2.1 IVD market for clinical chemistry, by type
10.5.2.2.2 IVD market for immunochemistry, by type
10.5.2.2.3 IVD market for molecular diagnostics, by type
10.5.2.2.4 IVD market for hematology, by type
10.5.2.3 By application
10.5.2.4 By end user
Chapter 11. Competitive Landscape
11.1 Global IVD Market Share of Key Players
11.2 Strategic Developments of Key Players
11.2.1 Product Launches and Approvals
11.2.2 Mergers and Acquisitions
11.2.3 Other Developments
Chapter 12. Company Profiles
12.1 Thermo Fisher Scientific Inc.
12.1.1 Business Overview
12.1.2 Product and Service Offerings
12.1.3 Key Financial Summary
12.2 Danaher Corporation
12.2.1 Business Overview
12.2.2 Product and Service Offerings
12.2.3 Key Financial Summary
12.3 F. Hoffmann-La Roche Ltd.
12.3.1 Business Overview
12.3.2 Product and Service Offerings
12.3.3 Key Financial Summary
12.4 PerkinElmer Inc.
12.4.1 Business Overview
12.4.2 Product and Service Offerings
12.4.3 Key Financial Summary
12.5 Quidel Corporation
12.5.1 Business Overview
12.5.2 Product and Service Offerings
12.5.3 Key Financial Summary
12.6 OraSure Technologies Inc.
12.6.1 Business Overview
12.6.2 Product and Service Offerings
12.6.3 Key Financial Summary
Want a report tailored exactly to your business strategy?
Request CustomizationWant an insight-rich discussion with the report author?
Speak to Analyst
Our dedication to providing the most-accurate market information has earned us verification by Dun & Bradstreet (D&B). We strive for quality checking of the highest level to enable data-driven decision making for you
Our insights into the minutest levels of the markets, including the latest trends and competitive landscape, give you all the answers you need to take your business to new heights
With 24/7 research support, we ensure that the wheels of your business never stop turning. Don’t let time stand in your way. Get all your queries answered with a simple phone call or email, as and when required
We take a cautious approach to protecting your personal and confidential information. Trust is the strongest bond that connects us and our clients, and trust we build by complying with all international and domestic data protection and privacy laws